AdvisorShares Gerber Kawasaki ETF (GK)
- Previous Close
19.44 - Open
19.07 - Bid --
- Ask --
- Day's Range
19.07 - 19.45 - 52 Week Range
15.33 - 21.01 - Volume
2,263 - Avg. Volume
3,695 - Net Assets 21.32M
- NAV 19.42
- PE Ratio (TTM) 25.71
- Yield 0.11%
- YTD Daily Total Return 7.00%
- Beta (5Y Monthly) 0.00
- Expense Ratio (net) 0.75%
The fund primarily invests in U.S. exchange traded equity securities, including common and preferred stock and ADRs. The fund may invest in companies of any capitalization but typically invests in companies with capitalizations of $1 billion or more. To a lesser extent, the fund may invest in ETFs, ETNs and other exchange-traded products (collectively with ETFs and ETNs, “ETPs”) to seek to obtain exposure to industries or sectors the Sub-Advisor believes to be top thematic macro opportunities. The fund is non-diversified.
AdvisorShares
Fund Family
Large Growth
Fund Category
21.32M
Net Assets
2021-07-01
Inception Date
Performance Overview: GK
Trailing returns as of 4/25/2024. Category is Large Growth.
People Also Watch
Holdings: GK
Top 10 Holdings (63.39% of Total Assets)
Sector Weightings
Related ETF News
Research Reports: GK
NATL: Raising target price to $24.00
NCR ATLEOS CORP has an Investment Rating of BUY; a target price of $24.000000; an Industry Subrating of Low; a Management Subrating of High; a Safety Subrating of High; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of High.
RatingPrice TargetEXPO: What does Argus have to say about EXPO?
EXPONENT INC has an Investment Rating of SELL; a target price of $68.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Medium.
RatingPrice TargetNATL: What does Argus have to say about NATL?
NCR ATLEOS CORP has an Investment Rating of BUY; a target price of $23.000000; an Industry Subrating of Low; a Management Subrating of High; a Safety Subrating of High; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of High.
RatingPrice TargetMLAB: Rating increased to a HOLD
MESA LABORATORIES INC has an Investment Rating of HOLD; a target price of $86.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of High.
RatingPrice Target